Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2021
Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II StudyDavid M O'Malley, Maryna Neffa, Bradley J Monk, et al.International Journal of Molecular Sciences|February 24, 2024
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2Lucía Paniagua-Herranz, Irene Moreno, Cristina Nieto-Jiménez, et al.Cancer Discovery|April 2, 2024
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint InhibitorsAdam J Schoenfeld, Sylvia M Lee, Bernard Doger de Spéville, et al.Nature Communications|March 14, 2023
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomasVictor Moreno, Maria Vieito, Juan Manuel Sepulveda, et al.Clinical and Translational Science|June 20, 2024
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b studyJoaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid TumorsMaria Vieito, Victor Moreno, Anna Spreafico, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumorsRavit Geva, Maria Vieito, Jorge Ramon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2025
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose EscalationCapucine Baldini, Loic Verlingue, Vincent Goldschmidt, et al.Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.Cancer Research Communications|April 26, 2024
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley StudyDuncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, et al.Pageof 4